#151778

Anti-vFlip [6/14]

Cat. #151778

Anti-vFlip [6/14]

Cat. #: 151778

Unit size: 100 ug

Availability: 3-4 weeks

Target: vFlip

Class: Monoclonal

Application: WB ; IHC; IP ; WB

Reactivity: Human

Host: Rat

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Mary Collins

Institute: University College London (UCL)

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-vFlip [6/14]
  • Research fields: Apoptosis and autophagy;Cell biology;Microbiology
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Human
  • Host: Rat
  • Application: WB ; IHC; IP ; WB
  • Description: v-FLIP synthesis can be up-regulated when apoptosis is triggered. It may provide a survival advantage for KSHV-infected cells under some circumstances and could be a reason for an IRES-dependent translation of v-FLIP. This antibody can be used to detect expression of latent vFLIP in KSHV infected cells and tumours and for examining the role of vFLIP in cell signaling.
  • Immunogen: Full-length recombinant v-FLIP expressed in Escherichia coli
  • Isotype: IgG

Target Details

  • Target: vFlip
  • Target background: v-FLIP synthesis can be up-regulated when apoptosis is triggered. It may provide a survival advantage for KSHV-infected cells under some circumstances and could be a reason for an IRES-dependent translation of v-FLIP. This antibody can be used to detect expression of latent vFLIP in KSHV infected cells and tumours and for examining the role of vFLIP in cell signaling.

Applications

  • Application: WB ; IHC; IP ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Low et al. 2001. J Virol. 75:2938-45 PMID: 11222719 Field et al. 2003. J Cell Sci. 116(Pt 18):3721-8. PMID: 12890756

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.